Literature DB >> 7707559

Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency.

S Debrus1, C Sadzot-Delvaux, A F Nikkels, J Piette, B Rentier.   

Abstract

Varicella-zoster virus (VZV) gene 63 encodes a protein with a predicted molecular mass of 30.5 kDa which has amino acid similarities with the immediate-early (IE) protein 22 (ICP-22) of herpes simplex virus type 1. In order to study the expression of this protein during lytic and latent infection, gene 63 was cloned in frame and downstream from the glutathione-S-transferase gene, expressed as a fusion protein, and purified. In VZV-infected Vero cells, antibodies directed against this protein detect two polypeptides of 45 and 38 kDa which are localized both in the cytoplasm and in the nucleus. Using a sequential combination of transcription and protein synthesis inhibitors (actinomycin D and cycloheximide, respectively), we demonstrated the immediate-early nature of this protein, which can thus be named IE63. Using a rat model of VZV latency, we showed that IE63 is heavily expressed, essentially in neurons, during latency. IE63 can also be detected in the skin of patients showing early herpes zoster symptoms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7707559      PMCID: PMC189034     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

2.  A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.

Authors:  L E Post; B Roizman
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

3.  Recovery of cell-free varicella virus from Vero cells.

Authors:  M Saito; C Haruyama; H Ohba; S Makino; M Matumoto
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

4.  Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27.

Authors:  H Moriuchi; M Moriuchi; H A Smith; J I Cohen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  Interaction with nucleic acids and stimulation of the viral DNA polymerase by the herpes simplex virus type 1 major DNA-binding protein.

Authors:  W T Ruyechan; A C Weir
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

6.  Comparative immunohistochemical study of herpes simplex and varicella-zoster infections.

Authors:  A F Nikkels; S Debrus; C Sadzot-Delvaux; J Piette; P Delvenne; B Rentier; G E Piérard
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product.

Authors:  P Defechereux; L Melen; L Baudoux; M P Merville-Louis; B Rentier; J Piette
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Varicella-zoster virus RNA in human trigeminal ganglia.

Authors:  R W Hyman; J R Ecker; R B Tenser
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

9.  Location and orientation of homologous sequences in the genomes of five herpesviruses.

Authors:  A J Davison; N M Wilkie
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

10.  Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes.

Authors:  W Batterson; B Roizman
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

View more
  64 in total

1.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking.

Authors:  S Mallory; M Sommer; A M Arvin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.

Authors:  Chantelle Hood; Anthony L Cunningham; Barry Slobedman; Ann M Arvin; Marvin H Sommer; Paul R Kinchington; Allison Abendroth
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  The IE180 protein of pseudorabies virus suppresses phosphorylation of translation initiation factor eIF2α.

Authors:  N Van Opdenbosch; C Van den Broeke; N De Regge; E Tabarés; H W Favoreel
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

5.  Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency.

Authors:  Hitoshi Sato; Lesley Pesnicak; Jeffrey I Cohen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Reactivated and latent varicella-zoster virus in human dorsal root ganglia.

Authors:  O Lungu; P W Annunziato; A Gershon; S M Staugaitis; D Josefson; P LaRussa; S J Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Search for varicella zoster virus and herpes simplex virus-1 in normal human cerebral arteries.

Authors:  Maria A Nagel; Alexander Choe; Nelly Khmeleva; Lindsey Overton; April Rempel; Ann Wyborny; Igor Traktinskiy; Don Gilden
Journal:  J Neurovirol       Date:  2013-03-01       Impact factor: 2.643

8.  Nuclear import of the varicella-zoster virus latency-associated protein ORF63 in primary neurons requires expression of the lytic protein ORF61 and occurs in a proteasome-dependent manner.

Authors:  Matthew S Walters; Christos A Kyratsous; Shilin Wan; Saul Silverstein
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63.

Authors:  Niklaus H Mueller; Matthew S Walters; Roland A Marcus; Laurie L Graf; Jessica Prenni; Don Gilden; Saul J Silverstein; Randall J Cohrs
Journal:  J Gen Virol       Date:  2010-01-20       Impact factor: 3.891

10.  Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.

Authors:  Maria A Nagel; Igor Traktinskiy; Kurt R Stenmark; Maria G Frid; Alexander Choe; Don Gilden
Journal:  Neurology       Date:  2012-12-12       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.